Mouse anti-MAX monoclonal antibody (CABT-B10622)

Mouse anti-Human MAX monoclonal antibody for WB, IF, sELISA, ELISA

Specifications


Host Species
Mouse
Antibody Isotype
IgG2a
Clone
5F212B0
Species Reactivity
Human
Immunogen
MAX (AAH03525, 1 a.a. ~ 152 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Conjugate
Unconjugated

Target


Alternative Names
MYC associated factor X; MGC10775; bHLHd4; MGC11225; bHLHd5; MGC18164
Entrez Gene ID
UniProt ID

Product Background


Pathway
C-MYC pathway, organism-specific biosystem; Cell Cycle, Mitotic, organism-specific biosystem; Cyclin A:Cdk2-associated events at S phase entry, organism-specific biosystem; Cyclin E associated events during G1/S transition, organism-specific biosystem; G1/S Transition, organism-specific biosystem; MAPK signaling pathway, organism-specific biosystem

Citations


Have you cited CABT-B10622 in a publication? Let us know and earn a reward for your research.

Custom Antibody Labeling


We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More

Customer Reviews


Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

References


Production, biochemical characterization, and kinetic/thermodynamic study of novel serine protease from Aspergillus avenaceus URM 6706

BIOTECHNOLOGY PROGRESS

Authors: da Silva, Anna Carolina; da Silva, Edson Flavio Teixeira; de Franca Queiroz, Alana Emilia Soares; de Oliveira, Rodrigo Lira; Porto, Tatiana Souza; de Sena, Amanda Reges; Ribeiro, Daniele Silva; Souza-Motta, Cristina Maria; Moreira, Keila Aparecida

This work aimed the characterization of protease produced by Aspergillus avenaceus URM 6706 from the Caatinga/Brazil. The optimization of production by central composite design increased the protease activity 15.47 times. The protease had a pH optimum of 7.0 and a temperature optimum of 50 degrees C. The enzyme activity was kept at 96.7 and 80% at a pH 7.0 and 40 degrees C, respectively for 180 min. No metal ion has altered a protease activity considerably. The sodium dodecyl sulfate (SDS) inhibited protease activity by 50%. The protease was inhibited by PMSF, so the enzyme is serine protease. The K-m, V-max, and k(cat) values were of 0.358 mg/ml, 16.31 mg center dot ml(-1)center dot min(-1), and 1.58 s(-1), respectively. The activation energy for the hydrolysis of azocasein catalyzed by protease also estimated (E* = 14.4 kJ/mol). Evaluating the protease thermal denaturation was observed that higher half-life values (277.2 <= t(1/2)<= 912.2 min) indicating a good thermostability confirmed by the results of thermodynamic parameters the activation energy for thermal inactivation (E*d = 100.3 kJ/mol), enthalpy (97.43 <=Delta H*d <= 97.64 kJ/mol), and Gibbs free energy (104.13 <=Delta G*d <= 104.77 kJ/mol). The results obtained suggest that this protease produced by A. avenaceus URM 6706, which proved to be thermostable and, could be profitably exploited in industrial applications.

Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks

REGULATORY TOXICOLOGY AND PHARMACOLOGY

Authors: Kale, Vijay Pralhad; Wallery, Jeffery; Novak, Joseph; Gibbs, Seth; Bourdi, Mohammed; Do, Minh-Ha T.; McKew, John C.; Terse, Pramod S.

Cyclocreatine (LUM-001), a creatine analog, was evaluated for its nonclinical toxicity in Sprague Dawley (SD) rats. Deionized water as a vehicle control article or cyclocreatine was administered by oral gavage twice daily (approximately 12 +/- 1 h apart) at 30, 100 and 300 mg/kg/dose levels in rats up to 26 weeks followed by a 28-day recovery period. Due to an increased incidence of seizures, the 600 mg/kg/day dose group males were dosed only for 16-weeks followed by a 14-week recovery period. Thirteen males and four females from 600 mg/kg/day dose group were sacrificed at interim on Day 113 to study plausible brain lesions and not due to moribundity. There was a dose dependent increase in the number of seizure incidences in >= 60 mg/kg/day males and 600 mg/kg/day females. Microscopically, higher incidences of vacuoles in the brain at 600 mg/kg/day in both sexes, thyroid follicular atrophy and follicular cell hypertrophy at >= 200 mg/kg/day in males and 600 mg/kg/day in females, and seminiferous tubular degeneration and/or interstitial edema in testes at >= 200 mg/kg/day were observed. Mean plasma half-life of cyclocreatine was between 3.5 and 6.5 h. In conclusion, chronic administration of cyclocreatine by oral gavage in Sprague Dawley rats induced the seizures and microscopic lesions in the brain, testes and thyroid. Based on the results of this study the highest tested dose of 600 mg/kg/day (mean C-max of 151.5 mu g/mL; AUC(0-24) of 1970 h*mu g/mL) was considered the maximum tolerated dose (MTD) in SD rats.

Online Inquiry

Name:
Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:

Related Products

Related Resources

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

Inquiry Basket